The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) will hold a workshop on early access approaches, including PRIME and breakthrough designations, on 26 November at the EMA ...
Last November, officials from the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) met with industry representatives in London to discuss the various quality challenges that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results